Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:IBM

IBM Common Stock (IBM)

235.68
+1.99 (0.85%)
as of Aug 21, 2026, 8:00:00 pm Market Open.
279 watching
0
Investor Insights
star iconAug 21, 2026, 12:00 am

This summary was created by AI, based on 24 opinions in the last 12 months.

IBM Common Stock, represented by the symbol IBM-N, has brought forward mixed sentiments among experts. While some express optimism over its long-term potential, particularly in AI and quantum computing, others highlight recent disappointing earnings and significant stock price drops. In terms of valuation, the stock trades at multiples ranging from 18x to 22x PE, leading to some experts suggesting it may be overvalued, especially considering its historical performance and recent volatility. Many experts also draw attention to its transition from hardware to services that could indicate a more sustainable business model. The overall sentiment suggests cautious optimism, with some experts advocating for buying during dips and others recommending to wait for clearer signals of recovery.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
GIB.A
DON'T BUY

Really good restructuring into higher-margin services. Can't seem to get out of its own way. Growth trajectory and margins are not compelling. Pretty sure dividend is safe. Not sure lots of upside, given current valuation.

HOLD

It is at a cheaper valuation and they are re-shaping themselves as a smaller company. You are not paying a big premium and he may consider buying it back.

BUY

They started to rest on their laurels when they got too big and lost their edge on AI. Their revenue is finally starting to go up. It compliments other tech areas and companies like NVIDIA and he owns it for the other side of AI.

PAST TOP PICK
(A Top Pick May 01/23, Up 59%)

Getting pricey, with a price target of $194.25, only a couple of dollars away. Keep your eye on it. Try to get it in the $180s, and $170s would be a great place to pick it up.

COMMENT

It has languished for many years compared to others in the same field. It has run up recently due to the AI frenzy/opportunity but there has been no big improvement in revenue and earnings. The largest component by far is consultation.

TOP PICK

Legacy name that's trying to adapt. Now much more about services and subscriptions. Getting into AI through Watson, which long ago beat a world-class chess player and won a bunch of money on Jeopardy! Partnered with META and OpenAI. 18x earnings, not expensive. Good yield of 3.37%.

(Analysts’ price target is $183.38)
BUY

Sold some AVGO to buy this recently. It trades at under 3x sales. Free cash flow has grown in the last 6 quarters from $7 billion to $12 billion, which he loves. Wants to see the 3% dividend grow. They get AI exposure through Red hat and Watson X. Shares have done nothing for 3-5 years, but the last quarter was excellent. It's old-school tech, but more conservative than AI stocks and is dividend-focused. It's not the old IBM. Very optimistic.

HOLD

Pretty fairly priced, price target is $194.25. One of the first on the AI bandwagon with Watson. Pretty significant play in the cloud, especially with Red Hat acquisition. Spun off hardware, now a software company. Decent runway.

BUY

Price target raised, though it's below the current share price. As we move into cloud, big data and AI, the big winners are in data like IBM. IBM is old and sleepy, but they bought Red Hat and will be a winner in this space, though not flashy but rather slow and steady. Pays a nearly 4% as you wait.

WEAK BUY

Open architecture through Red Hat, highly appealing. Long shot, but a possibility, that it'll be able to develop an open architecture to make it competitive in AI. If yes, it's going much higher. Getting act together, getting rid of legacy divisions. Don't go wild, but he wouldn't argue strenuously against adding it as part of a well-balanced portfolio.

BUY
Sell IBM or NXST?

He's uncertain about the industry that NXST is in, but confident about IBM who delivered an excellent quarter.

BUY ON WEAKNESS

First on the AI stage with "Watson", but fell short because of so many businesses. Much more a pure company now, that's why it's doing well and will be able to grow over next several years. Will benefit from cloud, but behind the leaders. He likes MSFT better, but IBM is cheaper.

PARTIAL SELL

AI has really played into its hands. Still has some of the legacy hardware. Short runway, take a bit of profit of about 1/3. If goes higher, you still own. If goes lower, you can buy it back.

(Analysts’ price target is $171.00)
BUY

It's finally breathing some life into its stock. The 4.1% dividend is one factor, and falling interest rates will help. Their Q1 and Q2 saw sales lighter than expected, though posted big earnings beat. However, they beat revenues and earnings last month, plus strong cash flow. The CEO has been touting hybrid AI to clients. Their key AI platform is Watson X, launched last spring. Their consulting business makes up a third of revenues but is overlooked. Shares trades at only 16x PE 2024. 43% of sales are from software, and 33% from consulting. This is consistent. IBM its recent upgrades.

DON'T BUY
IBM vs. MSFT

IBM lacks the spread of clientele like MSFT. Also, IBM has been getting rid of their hardware business, focusing more on software with AI. In terms of quality, MSFT is better (customer loyalty, Office Suite) while IBM is inferior, offering little growth. IBM isn't a big player moving forward. Among megatech, MSFT is the top.

Showing 61 to 75 of 452 entries